But it's coming at a cost to our non-crisis at the border, so if we don't have a crisis at the border why would we need to divert two billion dollars to take care of that non-crisis?
Lisa McClain
The Public Record
Lisa Carmella McClain is a member of the United States House of Representatives, representing Michigan's 10th congressional district. A member of the Republican Party, she has been in office since January 3, 2021. McClain has focused on issues such as fiscal responsibility and government accountability, advocating for policies like the Common Cents Act. She has also been vocal on social issues, emphasizing her party's stance against what she describes as divisive tactics from the Democratic Party.
Can you see my confusion is if we don't have a crisis at the border why are you diverting funds?
I don't know why it's a struggle to answer the question about a crisis at the border.
I mean we have 9.3 million jobs, and we don't have people to fill those jobs.
It is best to have American citizens working and making a positive contribution to our economy, rather than receiving unemployment benefits.
I continue to hear from employers and businesses in my district that they are unable to find people who are actually willing to work due to this administration's enhanced unemployment benefits.
The work at the Department of Labor is vital to continuing to ensure that all working families in America can lead more productive and safer lives.
You were brought here today to talk about the budget and agenda for the Department of Labor.
If we focus on what unites us, and we provide a positive message for our youth and a positive vision, we would just get a lot farther.
The disastrous situation at our southern border is not only a humanitarian crisis but a national security crisis, where former President Trump had the border secured.
As we all know, China has become an ever-increasing threat not only to the Pacific region, but globally.
As we all know, China has become an ever-increasing threat, not only to the Pacific region, but globally.
Even before the pandemic, Representative Garamendi and I had introduced a bill to bring back pharmaceutical production to America





